Shenzhen Salubris Pharmaceuticals Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 3,564.176 million compared to CNY 3,535.107 million a year ago. Operating income was CNY 847.102 million compared to CNY 1,357.447 million a year ago. Net income was CNY 716.943 million compared to CNY 1,150.007 million a year ago. Basic earnings per share from continuing operations was CNY 0.69 compared to CNY 1.1 a year ago.